Cargando…
Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims
Patient access and adherence to chronic medications is critical. In this work, we evaluate whether disruptions related to Covid-19 have affected new and existing patients’ access to pharmacological therapies without interruption. We do so by performing a retrospective analysis on a dataset of 9.4 bi...
Autores principales: | Clement, Jeffrey, Jacobi, Maura, Greenwood, Brad N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016279/ https://www.ncbi.nlm.nih.gov/pubmed/33793663 http://dx.doi.org/10.1371/journal.pone.0249453 |
Ejemplares similares
-
Diagnosis and management of hidradenitis suppurativa: Analysis of US insurance claims data
por: Xiong, Betty, et al.
Publicado: (2023) -
Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021) -
Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims
por: Desai, Rishi J., et al.
Publicado: (2019) -
Chronic Disease Onset Among People Living with HIV and AIDS in a Large Private Insurance Claims Dataset
por: Yang, Hsin-Yun, et al.
Publicado: (2019) -
Predictive costs in medical care for Koreans with metabolic syndrome from 2009 to 2013 based on the National Health Insurance claims dataset
por: Yoo, Jeong Seon, et al.
Publicado: (2020)